ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CBX Cellular Goods Plc

0.375
0.00 (0.00%)
13 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cellular Goods Plc LSE:CBX London Ordinary Share GB00BK964W87 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.375 0.35 0.40 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Catalog, Mail-order Houses 67k -3.31M -0.0055 -0.27 903.38k
Cellular Goods Plc is listed in the Catalog, Mail-order Houses sector of the London Stock Exchange with ticker CBX. The last closing price for Cellular Goods was 0.38p. Over the last year, Cellular Goods shares have traded in a share price range of 0.275p to 1.45p.

Cellular Goods currently has 602,250,000 shares in issue. The market capitalisation of Cellular Goods is £903,375 . Cellular Goods has a price to earnings ratio (PE ratio) of -0.27.

Cellular Goods Share Discussion Threads

Showing 1451 to 1472 of 2050 messages
Chat Pages: Latest  70  69  68  67  66  65  64  63  62  61  60  59  Older
DateSubjectAuthorDiscuss
07/12/2021
11:33
The move to 10p recently looks corrective. That means we could be going sub-1p here.

DYOR

david gruen
07/12/2021
11:30
I can assure people that i have zero intention of trying to buy back in as they say.
I am openly discussing what I see as many numerous pitfalls of investing in CBX and comparing them to a company that is using Cannabinoids but with medical licenses and potential to do so much good.
If you see this as some master plan to buy CBX at a penny less then i think stock investing is the wrong game for you.

Read the below: £42 BILLION market is not to be sniffed at.. And that is the market OCTP are targeting.

Imperial Brands, Casa Verde as backers

LONDON — Oxford Cannabinoid Technologies (OCTP), which enjoys backing from rapper Snoop Dogg and tobacco giant Imperial Brands, launched Friday on the London Stock Exchange.

The British company, which specializes in pain-alleviating cannabinoid drug development, raised gross proceeds of £16.5 million ($23.4 million) in its initial public offering, with a starting market value of just over £48 million ($69.1 million).

The share price hovered at around 5 pence at midday Friday, after opening near 8 pence.

Snoop Dogg, real name Calvin Broadus Jr., has invested in multiple cannabis start-ups including OCT through his venture capital firm Casa Verde. His firm has also backed plant-based food companies such as Outstanding Foods and tech names like Klarna, Robinhood and Reddit.

Cannabinoids are naturally occurring compound chemicals found in the cannabis sativa plant and are commonly used for medicinal purposes to treat symptoms such as chronic pain.

Oxford Cannabinoid CEO: We want to get our product into the hands of physicians and patients
OCTP’s strategy is to develop cannabinoid pharmaceuticals for the nonaddictive treatment of pain conditions. CEO John Lucas told CNBC on Friday the company plans to use the proceeds of its IPO to develop four new drugs.

“The key here is about getting cannabinoids into the hands of patients, and the way you do that is through the drug development process,” Lucas told CNBC’s “Squawk Box Europe.”

“The medical cannabis, the problem with that is that physicians cannot prescribe it, so we want a drug product that we can get into the hands of physicians, into the hands of patients.”

In its listing announcement, OCTP said its “primary market focus is the total addressable pain market, which is estimated to be worth at least £42.5 billion

whites123
07/12/2021
10:10
I think CBX holders with average of 10p and lower will get an opportunity to break even, but like others before have said I dont think that will come until into 2022.
The market for CBD products is flooded already. Even the new CEO came from a background where she was involved in releasing CBD products years ago. Its like trying to compete in a market for sandwiches after M&S have been doing them for 5 years already, along with every other supermarket chain. And suddenly your product is more expensive, has no history, no checkable factual evidence to show it works, but is much more expensive.
I took the decision to sell at a large loss...
Thankfully i did as I have saved myself from a further 30% drop in recent days and am pleased with where my investment is now heading.

Oxford Cannabinoid. "OCTP" In all honesty I believe fully that in time this will surpass a 10, 20, 30 bagger with ease, but it will not be about in the form we know it today.
It will be bought out by big pharma.

For the past 2 years big pharma has been directing resources at Covid.
Whilst they have many thousands of scientists you just need to look to Moderna to see other ground breaking work has taken a back seat.
Leaving it down to the small companies like OCTP to carry on the research.
What better research to be involved in that to find a pain relief that will assist those living with deadly diseases every day.
They make no bones about hiding the target is the Multi Billion £ pain relief market as just one target.
There are many hundreds of cannabinoids and we all know the wonderful well being properties this natural plant can provide.

At 50% lower than IPO and with big backers like Imperial Brands, is it not prudent to at least buy a few of these and tuck them away?
I certainly think so, so my few million shares are planted, and despite showing a profit already on them, i consider to add more to average up. :-)
Not very often in my share dealing career I have been happy to average up, but then never came across a stock with so much potential as OCTP before.

Its nothing like the other cannabis stocks which attract attention at present. CBX, KNB etc, these outfits are just fighting for the same consumer for CBD products along with thousands of others. No medical licenses and no medical properties, just a claim that it can make you look younger.. LOL

whites123
06/12/2021
18:35
As long as she ticks the 10 bagger box
oapknob1
06/12/2021
15:23
IDP going like a train.
gregpeck7
06/12/2021
14:50
I think that there will be another bite at the cherry from late January so will be buying back in then.

This is assuming that they don't announce some large sales before then.

ashleyjv
06/12/2021
14:31
I have accepted I'm never breaking even on this
bigballsbob1
06/12/2021
14:13
I announced my selling off last week of CBX despite holding at a loss for a long time.

Hindsight is wonderful and I am so glad i did sell.

I do of course hope you all claw your losses back.

In the meantime CBX are up against essentially thousands of CBD producers who put it into any item that can.

You can buy CBD oil for £30 a pop for a 25ml bottle for human consumption then buy the exact same oil in 250ml bottle from the vets for your dog.

The market is IMO saturated and we all know the healing properties come from the THC content..

OCTP is my pick of the cannabis plays.
Licensed and concentrating on medical issues like cancer pain.

Now this is something I want to see become big... Imagine the company producing pain relief for sufferers the world over from debilitating diseases.

WOW:

Hence the reasons I am now all in OCTP. Oxford cannabinoid

whites123
06/12/2021
11:46
The whole sector is oversold including all the big North American cannabis stocks.
sunnysideup1
06/12/2021
11:03
Looking oversold now, expect a reversal soon ,
7rademark
06/12/2021
08:16
Seems to have the track record but I dont suppose you mean that?
alloa2003
06/12/2021
07:36
I wonder how many boxes Anna Chokina ticks?
david gruen
06/12/2021
07:35
Good move with the new CEO - looks like the lady is very experienced.
alloa2003
03/12/2021
09:18
Chill Brands Group (CHLL) looks the better bet, as it's already selling dozens of products in thousands of stores, and product plus store rollout is continuing.
tell sid
03/12/2021
07:22
Sit back and relax
datait
03/12/2021
07:08
No nasty surprises with the figures - ahead of schedule if anything.
alloa2003
02/12/2021
23:12
Sell up and jog on then.
oapknob1
02/12/2021
18:10
Your pish is criminal.The skincare and ingestible product ranges will be available to purchase from early December 2021 accompanied by a comprehensive marketing activation, building to a full omni-channel launch at the start of February 2022. The timings are in-line with industry best-practice whereby new beauty and wellness products typically go on sale early in the year to coincide with consumers' focus on self-care and forming positive habits, as well as avoiding the hyper competitive pre-Christmas rush where return on ad spend is poor for new entrants.
oapknob1
02/12/2021
16:23
CCR1958,

You seem to be setting up the company for a fall. If you had read the recent announcement you would have seen that due to advertising expense and competition during the festive period, they were not going to make a big push for Xmas this year. Whether you agree or not they have been upfront about the reasons so suggesting that:-

"Also if they miss Xmas which looks like they are ,it’s criminal"

They have already answered your question.

alloa2003
02/12/2021
16:04
Also if they miss Xmas which looks like they are ,it’s criminal..
ccr1958
02/12/2021
12:51
Mr down ticker, why not supply something interesting. From their RNS in October, it looks like full marketing will start from February 22. Anyway here is latest YouTube video talking about product launch https://youtu.be/Z_ZCxjPNaHAHave not sold any share since purchasing. My minimum target is still 20p. GLH
kickingking
02/12/2021
12:04
Support at 5.5p
notknowing
Chat Pages: Latest  70  69  68  67  66  65  64  63  62  61  60  59  Older